Rapid Plasma Reagin Test Market (2021 to 2027) – Growth, Trends, COVID-19 Impact and Forecasts

Rapid Plasma Reagin Test Market was valued at US$ 37.2 Mn. in 2021 and is estimated to grow at a CAGR of 4.06 % over the forecast period.

Rapid Plasma Reagin Test Market Overview:

Rapid Plasma Reagin Test is a screening test for syphilis it measures proteins that are present in the blood of people who may have this disease. It is used to screen people who have symptoms of sexually transmitted infections and is routinely used to screen pregnant women for the disease. The report explores the Rapid Plasma Reagin Test market's segments (Type, Interferometer Type, Application, End-User, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). This market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2020. The report investigates the Rapid Plasma Reagin Test market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Rapid Plasma Reagin Test market's contemporary competitive scenario. Rapid Plasma Reagin Test Market To know about the Research Methodology :- Request Free Sample Report The COVID-19 pandemic has had a major impact across the world. During the time of the pandemic, there was a false allegation that the COVID-19 vaccine causes syphilis. Healthcare providers were continuously encouraging patients to get vaccinated against COVID-19 and to be aware of their patient’s vaccination status when interpreting reactive rapid plasma to regain. 2021 is considered as a base year to forecast the market from 2022 to 2027. 2021’s market size is estimated on real numbers and outputs of the key players and major players across the globe. The past five years' trends are considered while forecasting the market through 2027. 2020 is a year of exception and analysis, especially with the impact of lockdown by region.

Rapid Plasma Reagin Test Market Dynamics:

The most common factor driving the demand for Rapid Plasma Reagin Testing is the growing incidence of syphilis. Untreated syphilis during pregnancy leads to neonatal death. Bone deformities, and neurologic impairment of the child. All pregnant women should be tested at their first prenatal visit. The growing incidence of syphilis is a concern because it can further spread in the general population including reproductive-aged women. Therefore the health care centers rely on screening tests such as the RPR test and a treponemal confirmatory test. These testing strategies will surge the demand for RPR testing kits and instruments during the forecast period. Rapid Plasma Reagin Test Market Trends: The rapid market trend which is contributing to the growth of the RPR market is automated RPR systems that completely perform all the processes, dilutions, dispenses, and incubation. After the introduction of the automated RPR system in the laboratory, there is an increase in productivity and the quality and consistency of testing results have improved. It has reduced the amount of labor overhead and now the test results are directly uploaded to the laboratory database without the need for manual entry.

Rapid Plasma Reagin Test Market Segment Analysis:

Based on Type, the Rapid Plasma Reagin Test Market is segmented into Monoclonal Antibodies Test, Immunofluorescence Test, Fluorescent Treponemal Antibody Absorption Test, and T. Pallidum Hemagglutination Assay. The monoclonal antibody test is commonly used to detect antibodies present in the blood and cerebrospinal fluid. Fluorescent Treponemal Antibody Absorption Test is used for syphilis screening this test is highly sensitive but is non-specific. The market is dominated by monoclonal antibody tests and is expected to remain the same during the forecast period. Rapid Plasma Reagin Test Market Based on Application, the Rapid Plasma Reagin Test Market is segmented into hospitals, Specialty clinics, Diagnostics laboratories, and Others. The RPR testing in specialty clinic and diagnostic laboratory are less accepted by the people because the resource is limited and conditions for testing are poor. The RPR test which is done in hospitals holds the largest segment and will continue to remain the same during the forecast period.

Rapid Plasma Reagin Test Market Regional Insights:

The North American region held the largest market share accounting for 52% in 2021. The rising prevalence of syphilis will drive the growth of the Rapid Plasma Reagin Test market in this region. The Asia Pacific region is expected to witness significant growth at a CAGR of 6.7% through the forecast period. Due to technological advancement and the launch of new products, investment in healthcare infrastructure is fuelling the growth of the overall regional market to a large extent. The objective of the report is to present a comprehensive analysis of the global Rapid Plasma Reagin Test Barium Fluoride Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Rapid Plasma Reagin Test Market dynamic, and structure by analyzing the market segments and projecting the Rapid Plasma Reagin Test Market size. Clear representation of competitive analysis of key players by Design, price, financial position, product portfolio, growth strategies, and regional presence in the Rapid Plasma Reagin Test make the report investor’s guide.

Rapid Plasma Reagin Test Market Scope: Inquiry Before Buying

 Rapid Plasma Reagin Test Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US$ 37.2 Mn.
Forecast Period 2022 to 2027 CAGR: 4.06% Market Size in 2027: US$ 57.2 Mn.
Segments Covered: by Type • Monoclonal Antibodies Test • Immunofluorescence Test • Fluorescent Treponemal Antibody Absorption Test • T. Pallidum Hemagglutination Assay
by Application • Hospitals • Specialty clinics • Diagnostics laboratories • Others

Rapid Plasma Reagin Test Market by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Rapid Plasma Reagin Test Market Key Players:

• Bio Rad Laboratories Inc. • Cardinal Health Inc. • F. Hoffmann La Roche Ltd. • Innovatek Medical Inc. • Lorne Laboratories Ltd. • Mediclone Biotech • Newmarket Biomedical Ltd. • Novacyt SA • Sclavo Diagnostics International S.r.l. • Sekisui Chemical Co. Ltd. • Thermo Fisher Scientific Inc • Abbott Laboratories • Anamol Laboratories Pvt. Ltd. • ARKRAY Inc. • Arlington Scientific Inc. • Atlas Medical GmbH • Becton Dickinson and Co Frequently asked questions 1. What is the Rapid Plasma Reagin Test market size? Ans- The Rapid Plasma Reagin Test market growth will increase by $47Mn during the forecast period. 2. What is the CAGR for the Rapid Plasma Reagin Test market? Ans- The Rapid Plasma Reagin Test market is expected to grow at a CAGR of 4.5%. 3. What are the segments covered in the Rapid Plasma Reagin Test market? Ans- The segments covered in the Rapid Plasma Reagin Test market are type, application, and geography. 4. What are the key factors driving the growth of the Rapid Plasma Reagin Test market? Ans- Increasing incidence of syphilis and automated RPR systems are driving the growth of the market. 5. Which region is the highest growth rate in the Rapid Plasma Reagin Test market? Ans- Asia Pacific is growing at the highest CAGR during the forecast period.
1. Global Rapid Plasma Reagin Test Market Size: Research Methodology 2. Global Rapid Plasma Reagin Test Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Rapid Plasma Reagin Test Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Rapid Plasma Reagin Test Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Rapid Plasma Reagin Test Market Size Segmentation 4.1. Global Rapid Plasma Reagin Test Market Size, by type (2021-2027) • Monoclonal Antibodies Test • Immunofluorescence Test • Fluorescent Treponemal Antibody Absorption Test • T. Pallidum Hemagglutination Assay 4.2. Global Rapid Plasma Reagin Test Market Size, by application (2021-2027) • Hospitals • Specialty clinics • Diagnostics laboratories • Others 5. North America Rapid Plasma Reagin Test Market (2021-2027) 5.1. North America Rapid Plasma Reagin Test Market Size, by type (2021-2027) • Monoclonal Antibodies Test • Immunofluorescence Test • Fluorescent Treponemal Antibody Absorption Test • T. Pallidum Hemagglutination Assay 5.2. North America Rapid Plasma Reagin Test Market Size by application (2021-2027) • Hospitals • Specialty clinics • Diagnostics laboratories • Others 5.3. North America Rapid Plasma Reagin Test Market, by Country (2021-2027) • United States • Canada • Mexico 6. European Rapid Plasma Reagin Test Market (2021-2027) 6.1. European Rapid Plasma Reagin Test Market, by type (2021-2027) 6.2. European Rapid Plasma Reagin Test Market, by application (2021-2027) 6.3. European Rapid Plasma Reagin Test Market, by Country (2021-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Rapid Plasma Reagin Test Market (2021-2027) 7.1. Asia Pacific Rapid Plasma Reagin Test Market, by type (2021-2027) 7.2. Asia Pacific Rapid Plasma Reagin Test Market, by application (2021-2027) 7.3. Asia Pacific Rapid Plasma Reagin Test Market, by Country (2021-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Rapid Plasma Reagin Test Market (2021-2027) 8.1. Middle East and Africa Rapid Plasma Reagin Test Market, by type (2021-2027) 8.2. Middle East and Africa Rapid Plasma Reagin Test Market, by application (2021-2027) 8.3. Middle East and Africa Rapid Plasma Reagin Test Market, by Country (2021-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Rapid Plasma Reagin Test Market (2021-2027) 9.1. South America Rapid Plasma Reagin Test Market, by type (2021-2027) 9.2. South America Rapid Plasma Reagin Test Market, by application (2021-2027) 9.3. South America Rapid Plasma Reagin Test Market, by Country (2021-2027) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. Cardinal Health Inc. 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. F. Hoffmann La Roche Ltd. 10.3. Innovatek Medical Inc. 10.4. Lorne Laboratories Ltd. 10.5. Mediclone Biotech 10.6. Newmarket Biomedical Ltd. 10.7. Novacyt SA 10.8. Sclavo Diagnostics International S.r.l. 10.9. Sekisui Chemical Co. Ltd. 10.10. Thermo Fisher Scientific Inc 10.11. Abbott Laboratories 10.12. Anamol Laboratories Pvt. Ltd. 10.13. ARKRAY Inc. 10.14. Arlington Scientific Inc. 10.15. Atlas Medical GmbH 10.16. Becton Dickinson and Co

About This Report

Report ID 147198
Category Healthcare
Published Date May 2022
Updated Date
Contact Us